Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs
- 04 décembre 2024 - 1 mn de lecture
The purpose of this clinical phase I/II study is to investigate the safety and tolerability of 177Lu-OPS201 used for the treatment of patients with neuroendocrine tumors (NETs). Secondary objectives of these study are the assessment of biodistribution, dosimetry and preliminary efficacy of 177Lu-OPS201.
04 décembre 2024
1 mn de lecture
A Long-Term Study of Elafibranor in Adult Participants with Primary Biliary Cholangitis
04 décembre 2024
1 mn de lecture
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis.
04 décembre 2024
1 mn de lecture
A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants after Intake of a Single Tablet
04 décembre 2024
1 mn de lecture
Study to Compare the Level of Elafibranor in Blood after Repeat Administration in Japanese and non-Asian Healthy Participants
04 décembre 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
04 décembre 2024
1 mn de lecture
Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma.
04 décembre 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
04 décembre 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
04 décembre 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
04 décembre 2024
2 mn de lecture